Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing personalised medicine approaches to cancer, including targeted and cell therapies.
View the full Corporate Spotlight
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| PTX | Pitt Street Research 9July 2025 | 11:47 | 0 | 43 | |||
|
|||||||
| PTX | FY26 Share Price Prediction | 09:28 | 41 | 12K | |||
|
|||||||
| PTX | Ann: Prescient successfully completes $3 million Placement | 31/07/25 | 5 | 1.6K | |||
|
|||||||
| PTX | Ann: Proposed issue of securities - PTX | 31/07/25 | 0 | 231 | |||
|
|||||||
| PTX | Ann: June 2025 Quarterly Update and Appendix 4C | 30/07/25 | 0 | 404 | |||
|
|||||||
| PTX | Ann: Trading Halt | 30/07/25 | 18 | 6.1K | |||
|
|||||||
| PTX | Ann: Prescient announces results of SPP & Launches Placement | 29/07/25 | 3 | 1.4K | |||
|
|||||||
| PTX | Ann: Prescient Therapeutics - Extension of Share Purchase Plan | 28/07/25 | 29 | 10K | |||
|
|||||||
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.001(2.13%) |
Mkt cap ! $38.65M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.7¢ | $48.41K | 1.013M |
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 172076 | 4.7¢ |
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 338508 | 5 |
| Last trade - 11.12am 01/08/2025 (20 minute delay) ? |
|
|||||
|
Last
4.8¢ |
Change
0.001 ( 2.13 %) |
||||
| Open | High | Low | Volume | ||
| 4.8¢ | 4.8¢ | 4.8¢ | 10600 | ||
| Last updated 11.46am 01/08/2025 ? | |||||
| PTX (ASX) Chart |
ASX News
